These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 6249771

  • 21. Circadian rhythm of urinary 17-hydroxycorticosteroids during metyrapone-induced ACTH release in normal subjects.
    Angeli A, Fonzo D, Bertello P, Gaidano G, Ceresa F.
    Chronobiologia; 1975; 2(2):133-44. PubMed ID: 172298
    [Abstract] [Full Text] [Related]

  • 22. Modification of adrenal function by the anti-serotonin agent cyproheptadine.
    Plonk J, Feldman J.
    J Clin Endocrinol Metab; 1976 Feb; 42(2):291-5. PubMed ID: 177441
    [Abstract] [Full Text] [Related]

  • 23. [The use of a radioimmunologic method of analysis of 11-deoxycortisol for the evaluation of the function of the pituitary-adrenal cortex system during the metopirone test].
    Goncharov NP, Katsiia GV, Butnev VIu, Vorontsov VI, Khagundiukova LB.
    Vopr Med Khim; 1988 Feb; 34(1):130-3. PubMed ID: 3369121
    [Abstract] [Full Text] [Related]

  • 24. Hypothalamic-pituitary-adrenal axis interaction with prostaglandins.
    Thorén M, Stenfors C, Apéria B, Mathé AA.
    Prog Neuropsychopharmacol Biol Psychiatry; 1990 Feb; 14(3):319-26. PubMed ID: 2359842
    [Abstract] [Full Text] [Related]

  • 25. The metyrapone test in manic patients and healthy subjects.
    Perini GI, Fava GA, Morphy MA, Carson SW, Molnar G, Jusko WJ.
    Pharmacopsychiatry; 1984 May; 17(3):94-7. PubMed ID: 6739539
    [Abstract] [Full Text] [Related]

  • 26. Isolated ACTH deficiency: a heterogeneous disorder. Critical review and report of four new cases.
    Stacpoole PW, Interlandi JW, Nicholson WE, Rabin D.
    Medicine (Baltimore); 1982 Jan; 61(1):13-24. PubMed ID: 6276646
    [Abstract] [Full Text] [Related]

  • 27. Hypothalamic-pituitary-adrenal function in extrinsic asthma.
    Morrish DW, Sproule BJ, Aaron TH, Outhet D, Crockford PM.
    Chest; 1979 Feb; 75(2):161-6. PubMed ID: 217570
    [Abstract] [Full Text] [Related]

  • 28. Evidence against changes in corticotroph CRF receptors in depressed patients.
    Young EA, Akil H, Haskett RF, Watson SJ.
    Biol Psychiatry; 1995 Mar 15; 37(6):355-63. PubMed ID: 7772643
    [Abstract] [Full Text] [Related]

  • 29. A simple radioimmunoassay for plasma cortisol and 11-deoxycortisol (17, 21-dihydroxy-4-pregnene-3, 20-dione).
    Brown JR, Cavanaugh AH, Farnsworth WE.
    Steroids; 1976 Oct 15; 28(4):487-98. PubMed ID: 1034356
    [Abstract] [Full Text] [Related]

  • 30. A case of low cortisol-binding globulin: use of plasma free cortisol in interpretation of hypothalamic-pituitary-adrenal axis tests.
    Davidson JS, Bolland MJ, Croxson MS, Chiu W, Lewis JG.
    Ann Clin Biochem; 2006 May 15; 43(Pt 3):237-9. PubMed ID: 16704764
    [Abstract] [Full Text] [Related]

  • 31. The metyrapone test in pituitary dwarfs--the determination of serum cortisol and 11-deoxycortisol by high-performance liquid chromatography.
    Ginalska-Malinowska M, Małunowicz E, Romer TE, Filipek M.
    Endokrynol Pol; 1987 May 15; 38(1):21-7. PubMed ID: 2828014
    [No Abstract] [Full Text] [Related]

  • 32. Mineralocorticoid receptor function in posttraumatic stress disorder after pretreatment with metyrapone.
    Otte C, Muhtz C, Daneshkhah S, Yassouridis A, Kiefer F, Wiedemann K, Kellner M.
    Biol Psychiatry; 2006 Oct 01; 60(7):784-7. PubMed ID: 16566900
    [Abstract] [Full Text] [Related]

  • 33. Plasma metyrapone, adrenocorticotropic hormone, cortisol, and deoxycortisol levels. Sequential changes during oral and intravenous metyrapone administration.
    Jubiz W, Matsukura S, Meikle AW, Harada G, West CD, Tyler FH.
    Arch Intern Med; 1970 Mar 01; 125(3):468-71. PubMed ID: 4313727
    [No Abstract] [Full Text] [Related]

  • 34. The assessment of the hypothalamo-pituitary-adrenal axis in pituitary disease: are there short cuts?
    Dickstein G.
    J Endocrinol Invest; 2003 Mar 01; 26(7 Suppl):25-30. PubMed ID: 14604063
    [Abstract] [Full Text] [Related]

  • 35. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis.
    Fiad TM, Kirby JM, Cunningham SK, McKenna TJ.
    Clin Endocrinol (Oxf); 1994 May 01; 40(5):603-9. PubMed ID: 8013141
    [Abstract] [Full Text] [Related]

  • 36. Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative tests.
    Giordano R, Picu A, Bonelli L, Balbo M, Berardelli R, Marinazzo E, Corneli G, Ghigo E, Arvat E.
    Clin Endocrinol (Oxf); 2008 Jun 01; 68(6):935-41. PubMed ID: 18031311
    [Abstract] [Full Text] [Related]

  • 37. Overnight metyrapone and combined dexamethasone/metyrapone tests in post-traumatic stress disorder: preliminary findings.
    Kellner M, Otte C, Yassouridis A, Schick M, Jahn H, Wiedemann K.
    Eur Neuropsychopharmacol; 2004 Aug 01; 14(4):337-9. PubMed ID: 15163445
    [Abstract] [Full Text] [Related]

  • 38. The insulin hypoglycaemia and overnight metyrapone tests in the assessment of the hypothalamic-pituitary-adrenal axis following pituitary surgery.
    Courtney CH, McAllister AS, McCance DR, Hadden DR, Leslie H, Sheridan B, Atkinson AB.
    Clin Endocrinol (Oxf); 2000 Sep 01; 53(3):309-12. PubMed ID: 10971447
    [Abstract] [Full Text] [Related]

  • 39. Intravenous metyrapone testing. Evaluation of growth hormone and adrenocorticotrophic hormone in children.
    Bacon GE, Larson RM, Spencer ML, Kelch RP.
    Am J Dis Child; 1975 Sep 01; 129(9):1042-4. PubMed ID: 1190177
    [Abstract] [Full Text] [Related]

  • 40. Diagnosis of adrenal cortical dysfunction by liquid chromatography-tandem mass spectrometry.
    Kao PC, Machacek DA, Magera MJ, Lacey JM, Rinaldo P.
    Ann Clin Lab Sci; 2001 Apr 01; 31(2):199-204. PubMed ID: 11337910
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.